Day: August 2, 2021

LONDON, Aug. 02, 2021 (GLOBE NEWSWIRE) — OKYO Pharma Limited (the “Company”) is pleased to announce its final audited results for the year ended 31 March 2021. Summary of OKYO-101 studies during the last yearOK-101 is designed to target a chemokine-like receptor 1, or CMKLR1, which is a G protein-coupled receptor, or GPCR, expressed on macrophages, monocytes, plasmacytoid/myeloid dendritic cells, natural killer cells and nonhemopoietic cell types, such as endothelial and epithelial cells. Activation of CMKLR1 by its endogenous peptide ligand chemerin is known to modulate inflammation, but natural ligands for CMKLR1 have short half-lives due to rapid inactivation. To characterize the potential efficacy of OK-101 to treat DED, OK-101 was tested in a mouse model of acute dry eye disease induced with scopolamine that showed an increase...

To NASDAQ Copenhagen   Executive Board Lersø Parkallé 100 DK-2100 København Ø www.rd.dk Telephone +45 7012 5300 Telefax +45 4514 9622 2 August 2021  Prepayments, Realkredit Danmark A/S Pursuant to §24 of the Capital Markets Act, Realkredit Danmark A/S hereby publishes prepayments as at Friday 30 July 2021. Please find the data in the attached file. The information will also be available on www.rd.dk.   Yours sincerely The Executive Board   Any additional questions should be addressed to Hella Gebhardt Rønnebæk, Chief Analyst, phone +45 4513 2068.      AttachmentsNr. 67_Ekstraordinaere indfrielser pr. 30.07.2021_ukBilag til selskabsmeddelelse nr. 67-2021

Company Also Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) RESEARCH TRIANGLE PARK, N.C., Aug. 02, 2021 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the appointment of Andrew Perry as its Chief Commercial Officer (CCO). Mr. Perry replaces Soma Gupta who has left the Company for personal and professional reasons. “As we continue to evolve as a commercial company and execute on the launch of COSELA™ (trilaciclib), we are excited to announce the addition of Andrew to the G1 Therapeutics Executive Team,” said Jack Bailey, Chief Executive Officer of G1 Therapeutics. “Andrew is a proven leader and strategist with a history of driving consistent performance and commercial success; his extensive capabilities and depth of experience in launching and growing...

CONSHOHOCKEN, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, a clinical-stage biopharmaceutical company pursuing novel therapeutics for cardio-metabolic and fatty liver diseases with high unmet medical need, announced today that Dr. Robert Waltermire has joined Madrigal as Chief Pharmaceutical Development Officer. “We are pleased to announce that Dr. Robert Waltermire has joined the Madrigal R&D team. With over 30 years of experience in pharmaceutical development, Rob brings proven expertise in all aspects of chemistry, manufacturing and control (CMC) as well as experience in manufacturing new commercial products,” stated Becky Taub, M.D., President R&D and CMO of Madrigal. Paul Friedman, CEO of Madrigal added, “We look forward to reconnecting with Rob at Madrigal after having worked with him at...

WEST PALM BEACH, Fla., Aug. 02, 2021 (GLOBE NEWSWIRE) — Ocwen Financial Corporation (NYSE: OCN) (“Ocwen” or the “Company”), a leading non-bank mortgage servicer and originator, today announced that it will hold a conference call on Thursday, August 5, 2021 at 8:30 a.m. (ET) to review the Company’s second quarter 2021 operating results and provide a business update. All interested parties are welcome to participate. You can access the conference call by dialing (877) 344-8082 or (213) 992-4618 approximately 10 minutes prior to the call. Participants can also access the conference call through a live audio webcast available from the Shareholder Relations page at www.ocwen.com under Events and Presentations. An investor presentation will accompany the conference call and be available by visiting the Shareholder Relations page at www.ocwen.com...

BROOKFIELD, NEWS, Aug. 02, 2021 (GLOBE NEWSWIRE) — Brookfield Business Partners L.P. (“Brookfield Business Partners” or “BBU”) (NYSE: BBU; TSX: BBU.UN) today announced the intention to create a Canadian corporation to provide investors with greater flexibility to invest in BBU’s globally diversified services and industrial operations and the targeted returns associated with BBU’s growth strategy. Brookfield Business Partners intends to distribute to existing unitholders, class A shares of the new corporation, Brookfield Business Corporation (“BBUC”). From an economic and accounting perspective, the transaction will be analogous to a unit split as it will not result in any underlying change to BBU’s aggregate cash flows or net asset value except for the adjustment for the number of units/shares outstanding. “The creation of BBUC...

CONTINUING STRONG MOMENTUM ACROSS ALL REGIONS Ferrari N.V. (NYSE/MTA: RACE) (“Ferrari” or the “Company”) today announces its consolidated preliminary results for the second quarter and six months ended June 30, 2021. Second quarter results can be summarized as follows:Total shipments of 2,685 units, almost doubled versus prior year and up 0.5% versus Q2 2019Net revenues of Euro 1,035 million, nearly doubled versus prior year and up 5.2% versus Q2 2019 EBITDA of Euro 386 million, tripled versus prior year and up 23.0% versus Q2 2019. EBITDA margin of 37.4% in Q2 2021. EBIT of Euro 274 million versus Euro 23 million of prior year and up 14.8% versus Q2 2019. EBIT margin of 26.5% in Q2 2021. Net profit of Euro 206 million and diluted EPS at Euro 1.11 Sound industrial free cash flow generation of Euro 113 million and guidance...

Talenom Plc, Half-Year Financial Report, 2 August 2021 at 13:30 EEST Talenom Plc Half-Year Report January–June 2021 (unaudited): Net sales increased by 23% and operating profit improved by 17% – Growth accelerated, earnings improved and strategy implementation progressed This release is a summary of Talenom Plc’s Half-Year Report January–June 2021. The complete Half-Year Report is attached to this release as a pdf file. It is also available on the company’s website at www.talenom.fi/en/investors. January–June 2021 in brief: Net sales 41.7 (33.9) million euros, increase 23.1% (14.6%)  Operating profit (EBIT) 8.6 (7.3) million euros, 20.5% (21.6%) of net sales  Net profit 6.4 (5.5) million euros  Earnings per share 0.15 (0.13) eurosGroup 1–6/2021 1–6/2020 ChangeNet sales, thousands of euro 41,687 33,852 7,835Net sales,...

AKVA group ASA hereby invites you to the presentation of the Q2 2021 financial results, which will take place as follows: Time: Friday 13 August 2021 at 10:00 CET Webcast: https://channel.royalcast.com/landingpage/hegnarmedia/20210813_2/ A recorded version of the presentation will be available after the live stream is concluded. The presentation will be held in English and is open to all interested parties. Dated: 2 August 2021 AKVA group ASA Web: www.akvagroup.com CONTACTS:Knut Nesse Chief Executive OfficerPhone: +47 51 77 85 00Mobile: +47 91 37 62 20E-mail: knesse@akvagroup.comRonny Meinkøhn Chief Financial OfficerPhone: +47 51 77 85 00Mobile: +47 98 20 67 76E-mail: rmeinkohn@akvagroup.comThis information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading...

Midland, TX, Aug. 02, 2021 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (NYSE:NGS), a leading provider of gas compression equipment and services to the natural gas industry, announces  the following conference call information for their second quarter 2021 earnings release: Earnings Release: Thursday, August 12, 2021 before market opens Public distribution will be through Nasdaq OMX and the Natural Gas Services Group, Inc. website at www.ngsgi.com. Conference Call: Thursday, August 12, 2021 at 10:00 a.m. Central, 11:00 a.m. Eastern  Live via phone by dialing 877-358-7306, pass code “Natural Gas Services”. All attendees and participants to the conference call should arrange to call in at least 5 minutes prior to the start time. Conference Call Replay For those unable to attend the live teleconference, a Webcast...